Artivion, Inc. (AORT) stock
AORTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 8/3021% above fair value
$19.10−0.30 (-1.55%)
Close on Nov 13, 2026Market cap $931.24MP/E –Yield –
Artivion total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Artivion's total debt was $363.79M at Sep 30, 2026. For fiscal 2025 it was $215.11M, down 31.6% from the year before. The highest annual figure on record is $314.35M in fiscal 2024.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $215.11M | -31.6% |
| FY2024 | Dec 31, 2024 | $314.35M | +2.4% |
| FY2023 | Dec 31, 2023 | $306.98M | -0.4% |
| FY2022 | Dec 31, 2022 | $308.11M | -0.3% |
| FY2021 | Dec 31, 2021 | $309.12M | +6.0% |
| FY2020 | Dec 31, 2020 | $291.66M | +35.2% |
| FY2019 | Dec 31, 2019 | $215.74M | -0.5% |
| FY2018 | Dec 31, 2018 | $216.88M | -0.9% |
| FY2017 | Dec 31, 2017 | $218.95M | +205.9% |
| FY2016 | Dec 31, 2016 | $71.57M | – |
| FY2012 | Dec 31, 2012 | $0 | – |
| FY2011 | Dec 31, 2011 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $363.79M | +69.3% |
| Q2 FY2026 | Jun 30, 2026 | $363.42M | +68.6% |
| Q1 FY2026 | Mar 31, 2026 | $215.35M | -31.6% |
| Q4 FY2025 | Dec 31, 2025 | $215.11M | -31.6% |
| Q3 FY2025 | Sep 30, 2025 | $214.87M | -31.6% |
| Q2 FY2025 | Jun 30, 2025 | $215.61M | -31.2% |
| Q1 FY2025 | Mar 31, 2025 | $314.75M | +0.5% |
| Q4 FY2024 | Dec 31, 2024 | $314.35M | +2.4% |
| Q3 FY2024 | Sep 30, 2024 | $313.97M | +2.1% |
| Q2 FY2024 | Jun 30, 2024 | $313.56M | +1.9% |
| Q1 FY2024 | Mar 31, 2024 | $313.27M | +1.7% |
| Q4 FY2023 | Dec 31, 2023 | $306.98M | -0.4% |
| Q3 FY2023 | Sep 30, 2023 | $307.43M | -0.3% |
| Q2 FY2023 | Jun 30, 2023 | $307.67M | -0.3% |
| Q1 FY2023 | Mar 31, 2023 | $307.90M | -0.3% |
| Q4 FY2022 | Dec 31, 2022 | $308.11M | -0.3% |
| Q3 FY2022 | Sep 30, 2022 | $308.24M | -0.4% |
| Q2 FY2022 | Jun 30, 2022 | $308.53M | -0.4% |
| Q1 FY2022 | Mar 31, 2022 | $308.85M | -0.8% |
| Q4 FY2021 | Dec 31, 2021 | $309.12M | +6.0% |
| Q3 FY2021 | Sep 30, 2021 | $309.41M | +6.4% |
| Q2 FY2021 | Jun 30, 2021 | $309.70M | +6.8% |
| Q1 FY2021 | Mar 31, 2021 | $311.23M | +26.8% |
| Q4 FY2020 | Dec 31, 2020 | $291.66M | +35.2% |
| Q3 FY2020 | Sep 30, 2020 | $290.86M | +34.7% |
| Q2 FY2020 | Jun 30, 2020 | $290.08M | +34.2% |
| Q1 FY2020 | Mar 31, 2020 | $245.38M | +13.4% |
| Q4 FY2019 | Dec 31, 2019 | $215.74M | -0.5% |
| Q3 FY2019 | Sep 30, 2019 | $215.94M | -0.9% |
| Q2 FY2019 | Jun 30, 2019 | $216.18M | -0.9% |
| Q1 FY2019 | Mar 31, 2019 | $216.41M | -1.1% |
| Q4 FY2018 | Dec 31, 2018 | $216.88M | -0.9% |
| Q3 FY2018 | Sep 30, 2018 | $217.85M | +220.0% |
| Q2 FY2018 | Jun 30, 2018 | $218.20M | +216.9% |
| Q1 FY2018 | Mar 31, 2018 | $218.74M | +207.0% |
| Q4 FY2017 | Dec 31, 2017 | $218.95M | +205.9% |
| Q3 FY2017 | Sep 30, 2017 | $68.07M | – |
| Q2 FY2017 | Jun 30, 2017 | $68.86M | – |
| Q1 FY2017 | Mar 31, 2017 | $71.24M | – |
| Q4 FY2016 | Dec 31, 2016 | $71.57M | – |
See a number that looks wrong?